Frontlight ResearchEarly access
Trial site
Montreal Neurological Institute
- 5running trials
- 2closed trials
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Myotonic dystrophy3 trials
- ALS (motor neurone disease)2 trials
- Charcot-Marie-Tooth disease1 trial
- Parkinson disease1 trial
- Sarcoma1 trial
- Phase
- Phase 23 trials
- Phase 33 trials
- Phase 11 trial
- Status
- Recruiting3 trials
- Completed2 trials
- Active, not recruiting1 trial
- Enrolling by invitation1 trial
- Lead sponsor
- Avidity Biosciences, Inc.2 trials
- Biogen1 trial
- Ionis Pharmaceuticals, Inc.1 trial
- Novartis Pharmaceuticals1 trial
- Oliver Blanchard1 trial
- and 1 more
Running trials
Recruiting
Enrolling by invitation
Global Open-Label Extension Study of Del-desiran for the Treatment of DM1
Recruiting
A Clinical Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1
Recruiting
A Study to Assess the Safety, Tolerability, and Pharmacology of Darifenacin in Patients With ALS
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Myotonic dystrophy2 recruiting
- ALS (motor neurone disease)1 recruiting
- Charcot-Marie-Tooth disease1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 15 Nov 2026